Progression-Free Survival and Clinical Outcomes with Long-Term Use of Telotristat Ethyl in US Clinical Practice

被引：0
|
作者：
Metz, D. C. [1 ]
Liu, E. [2 ]
Joish, V. N. [3 ]
Huynh, L. [4 ]
Cheng, M. [4 ]
Kunzweiler, C. [4 ]
Duh, M. S. [4 ]
Giacalone, S. [3 ]
Lapuerta, P. [3 ]
Morse, M. A. [5 ]
机构：
[1] Neuroendocrine Tumor Ctr Penn Med, Philadelphia, PA USA
[2] Rocky Mt Canc Ctr, Neuroendocrine Inst, Denver, CO USA
[3] Lexicon Pharmaceut Inc, The Woodlands, TX USA
[4] Anal Grp, Boston, MA USA
[5] Duke Univ, Sch Med, Duke Canc Inst, Durham, NC USA
来源：
NEUROENDOCRINOLOGY | 2020年 / 110卷
关键词：
neuroendocrine tumor; carcinoid syndrome; telotristat ethyl; serotonin; tumor growth; progression-free survival;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
H21
引用
收藏
页码：198 / 198
页数：1
相关论文
共 50 条
  • [21] Radiographic Progression-Free Survival and Clinical Progression-Free Survival as Potential Surrogates for Overall Survival in Men With Metastatic Hormone-Sensitive Prostate Cancer
    Halabi, Susan
    Roy, Akash
    Rydzewska, Larysa
    Guo, Siyuan
    Godolphin, Peter
    Hussain, Maha
    Tangen, Catherine
    Thompson, Ian
    Xie, Wanling
    Carducci, Michael A.
    Smith, Matthew R.
    Morris, Michael J.
    Gravis, Gwenaelle
    Dearnaley, David P.
    Verhagen, Paul
    Goto, Takayuki
    James, Nick
    Buyse, Marc E.
    Tierney, Jayne F.
    Sweeney, Christopher
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (09)
  • [22] Improved Progression-Free Long-Term Survival of a Nation-Wide Patient Population with Metastatic Melanoma
    Soerensen, Anne Vest
    Ellebaek, Eva
    Bastholt, Lars
    Schmidt, Henrik
    Donia, Marco
    Svane, Inge Marie
    CANCERS, 2020, 12 (09) : 1 - 11
  • [23] A case of complete response to nivolumab after long-term progression-free survival with tyrosine kinase inhibitor
    Mollica, Veronica
    Di Nunno, Vincenzo
    Corcioni, Beniamino
    Fiorentino, Michelangelo
    Nobili, Elisabetta
    Schiavina, Riccardo
    Golfieri, Rita
    Brunocilla, Eugenio
    Ardizzoni, Andrea
    Massari, Francesco
    ANTI-CANCER DRUGS, 2018, 29 (09) : 911 - 913
  • [24] Long-term progression-free survival after early autologous transplantation for mantle-cell lymphoma
    S Murali
    E Winton
    E K Waller
    L T Heffner
    S Lonial
    C Flowers
    J Kaufman
    M Arellano
    M J Lechowicz
    K P Mann
    H J Khoury
    A A Langston
    Bone Marrow Transplantation, 2008, 42 : 529 - 534
  • [25] Long-term progression-free survival of third-line apatinib in lung squamous cell carcinoma
    Li, Xiaofen
    Li, Xia
    Fang, Xuefeng
    Yuan, Ying
    ONCOTARGETS AND THERAPY, 2018, 11 : 4047 - 4050
  • [26] Long-term progression-free survival after early autologous transplantation for mantle-cell lymphoma
    Murali, S.
    Winton, E.
    Waller, E. K.
    Heffner, L. T.
    Lonial, S.
    Flowers, C.
    Kaufman, J.
    Arellano, M.
    Lechowicz, M. J.
    Mann, K. P.
    Khoury, H. J.
    Langston, A. A.
    BONE MARROW TRANSPLANTATION, 2008, 42 (08) : 529 - 534
  • [27] Long-term clinical outcomes of patients with autoimmune hepatitis and predictors of survival
    Jayabalan, D.
    Adams, L. A.
    Huang, Y.
    Bertot, L. Calzadilla
    De Boer, B.
    Joseph, J.
    Chang, W.
    Hazeldine, S.
    Smith, B.
    Macquillan, G.
    Wallace, M.
    Garas, G.
    Jeffrey, G. P.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 50 - 51
  • [28] Complete response correlates with long-term survival and progression-free survival in high-dose therapy in multiple myeloma
    van de Velde, Helgi J. K.
    Liu, Xiangyang
    Chen, Gang
    Cakana, Andrew
    Deraedt, William
    Bayssas, Martine
    HAEMATOLOGICA, 2007, 92 (10) : 1399 - 1406
  • [29] Rethinking Progression-Free Survival (PFS) as a Clinical Trials Surrogate for Overall Survival (OS)
    Stewart, D.
    Bosse, D.
    Ocana, A.
    Goss, G.
    Jonker, D.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1782 - S1782
  • [30] Lenalidomide Maintenance Prolongs Progression-Free Survival and Does Not Impact the Aggressiveness of Clinical Relapse: Data from Long-Term Follow up of the Myeloma XI Trial
    Pawlyn, Charlotte
    Davies, Faith E.
    Royle, Kara-Louise
    Cairns, David
    Cook, Gordon
    Drayson, Mark T.
    Gregory, Walter M.
    Jenner, Matthew
    Jones, John R.
    Kaiser, Martin F.
    Owen, Roger G.
    Russell, Nigel H.
    Morgan, Gareth
    Jackson, Graham
    BLOOD, 2019, 134
12345